Banking & Finance  September 30, 2022

Funding Friday: Arpeggio Biosciences raise $17M in Series A

Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers.

BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com.

Notable rounds this week:

SPONSORED CONTENT

Business Cares: February 2024

This Month’s Featured Nonprofit: At the Boulder Community Health (BCH) Foundation our donors have partnered with us to invest in the best medical resources available to support the treatment and recovery of our patients. Our staff and physicians recognize that providing the best quality of care can sometimes mean assisting patients with the social and … Continued

  • Peregrine Private Equity Fund II LP, a private equity fund managed by Boulder boutique investment firm Schoolcraft Capital LLC, raised $20.4 million.
  • Boulder bioscience company Arpeggio Biosciences Inc., which develops RNA-based drugs, raised $17 million in a Series A funding round that was led by Builders VC.

Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers.

BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com.

Notable rounds this week:

  • Peregrine Private Equity Fund II LP, a private equity fund managed by Boulder boutique investment firm Schoolcraft Capital LLC, raised $20.4 million.
  • Boulder bioscience company Arpeggio Biosciences Inc., which develops RNA-based drugs, raised $17 million in a Series A funding round that was led by Builders…

Sign up for BizWest Daily Alerts

Related Content